nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00318	0.00318	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00316	0.00316	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.003	0.003	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.00299	0.00299	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00299	0.00299	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00298	0.00298	CbGpPWpGaD
Darifenacin—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00296	0.00296	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00295	0.00295	CbGpPWpGaD
Darifenacin—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00294	0.00294	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—TRH—narcolepsy	0.00287	0.00287	CbGpPWpGaD
Darifenacin—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Darifenacin—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Darifenacin—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00278	0.00278	CbGpPWpGaD
Darifenacin—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00278	0.00278	CbGpPWpGaD
Darifenacin—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00277	0.00277	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—TRH—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00263	0.00263	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—HCRTR2—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—HCRTR1—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Darifenacin—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Darifenacin—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Darifenacin—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00253	0.00253	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—P2RY11—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—HRH3—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—HCRTR2—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—HCRTR1—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—P2RY11—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—HRH3—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Darifenacin—CHRM5—G alpha (q) signalling events—HTR2A—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—HCRTR1—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—HCRTR2—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—P2RY11—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—HCRTR2—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—HCRTR1—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00225	0.00225	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00223	0.00223	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0022	0.0022	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—P2RY11—narcolepsy	0.00219	0.00219	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—HCRT—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Darifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00213	0.00213	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—TAC1—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—NPS—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—HCRT—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—NPS—narcolepsy	0.002	0.002	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—TAC1—narcolepsy	0.002	0.002	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—HCRT—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00193	0.00193	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00193	0.00193	CbGpPWpGaD
Darifenacin—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—PENK—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—HCRT—narcolepsy	0.00186	0.00186	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Darifenacin—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—PENK—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—PENK—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Darifenacin—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Darifenacin—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—PENK—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—TRH—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00157	0.00157	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00157	0.00157	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—TRH—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—TRH—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—HRH3—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—TRH—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HCRTR2—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HCRTR1—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—HRH3—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—P2RY11—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HCRTR2—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HCRTR1—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Darifenacin—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—P2RY11—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Darifenacin—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—HRH3—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Darifenacin—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CHKB—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—HTR2A—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—HRH3—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—HTR2A—narcolepsy	0.0012	0.0012	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—NPS—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—TAC1—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HCRT—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—NPS—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—TAC1—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HCRT—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—NPS—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—TAC1—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—TAC1—narcolepsy	0.00102	0.00102	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—NPS—narcolepsy	0.00102	0.00102	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PENK—narcolepsy	0.00102	0.00102	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.000993	0.000993	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.00099	0.00099	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.00098	0.00098	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PENK—narcolepsy	0.00098	0.00098	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000959	0.000959	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.000956	0.000956	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.000946	0.000946	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000942	0.000942	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000942	0.000942	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.000939	0.000939	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.000939	0.000939	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.00093	0.00093	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.00093	0.00093	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.00091	0.00091	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.000907	0.000907	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.000898	0.000898	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.000871	0.000871	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TRH—narcolepsy	0.00087	0.00087	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.000868	0.000868	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CPT1B—narcolepsy	0.000867	0.000867	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.000859	0.000859	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000846	0.000846	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.000843	0.000843	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.000835	0.000835	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TRH—narcolepsy	0.000833	0.000833	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000823	0.000823	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000794	0.000794	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.000794	0.000794	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.000792	0.000792	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.000792	0.000792	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.000784	0.000784	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.000784	0.000784	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.000774	0.000774	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.000771	0.000771	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.000764	0.000764	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CHKB—narcolepsy	0.000763	0.000763	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HRH3—narcolepsy	0.000763	0.000763	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HRH3—narcolepsy	0.00073	0.00073	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.000721	0.000721	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.000721	0.000721	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.000719	0.000719	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.000719	0.000719	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.000712	0.000712	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.000712	0.000712	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—HTR2A—narcolepsy	0.000709	0.000709	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PENK—narcolepsy	0.00069	0.00069	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PENK—narcolepsy	0.000688	0.000688	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000681	0.000681	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—HTR2A—narcolepsy	0.000679	0.000679	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—HTR2A—narcolepsy	0.000644	0.000644	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TAC1—narcolepsy	0.000632	0.000632	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NPS—narcolepsy	0.000632	0.000632	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—HTR2A—narcolepsy	0.000616	0.000616	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TAC1—narcolepsy	0.000605	0.000605	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NPS—narcolepsy	0.000605	0.000605	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000586	0.000586	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TRH—narcolepsy	0.000585	0.000585	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TRH—narcolepsy	0.000579	0.000579	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000519	0.000519	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000514	0.000514	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.000513	0.000513	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000508	0.000508	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CHKB—narcolepsy	0.000499	0.000499	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000478	0.000478	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.000476	0.000476	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000472	0.000472	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000434	0.000434	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000433	0.000433	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.000428	0.000428	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000426	0.000426	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000426	0.000426	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NPS—narcolepsy	0.000425	0.000425	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.000425	0.000425	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000421	0.000421	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000421	0.000421	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HTR2A—narcolepsy	0.00038	0.00038	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HTR2A—narcolepsy	0.000364	0.000364	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000339	0.000339	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000256	0.000256	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000256	0.000256	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000253	0.000253	CbGpPWpGaD
